tiprankstipranks
Trending News
More News >
Day One Biopharmaceuticals (DAWN)
NASDAQ:DAWN
US Market

Day One Biopharmaceuticals (DAWN) Revenue

Compare
323 Followers

Day One Biopharmaceuticals Revenue

Day One Biopharmaceuticals had a revenue of 29.21M in the quarter ending Dec 31, 2024, with -68.85%. This bring the company's revenue in the last twelve months to 131.16M, Decreased 27.95%. In the fiscal year ending Dec 31, 2024, Day One Biopharmaceuticals had annual revenue of 131.16M with Infinity% growth.
Revenue (ttm)
131.16M
Revenue Growth
P/S Ratio
6.13
Revenue/Employee
$724,646
Employees
181
Market Cap
$803.74M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024131.16M+∞%
Dec 31, 20230.00
Dec 31, 20220.00
Dec 31, 20210.00
Dec 31, 20200.00
Dec 31, 20190.00
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis